This week’s comparison update: where the parent site now gives a clearer shortlist
A short update on where the parent comparison now gives a clearer shortlist before readers move deeper.
This week’s update is about where the parent site now does a better job of helping readers narrow the field before they move into deeper comparisons. The goal is not to keep readers on one page forever. It is to help them reach the right next page with a clearer shortlist already in mind.
Where the shortlist is clearer now
- the treatment and comparison hubs now show more clearly what can be compared on the parent site today
- provider and tablet treatments now give readers cleaner reasons to click deeper
- more articles now route back into live comparison pages instead of ending as standalone reading
What this means for the reader journey
If the question is still broad, the parent site should now make it easier to stay broad in a useful way. If the question becomes specifically about current Wegovy or Mounjaro provider detail, the next step should also feel more obvious rather than abrupt.
Good next pages after this update
Common questions about the shortlist update
Does a clearer shortlist mean the parent site replaces the specialist sites?
No. The parent site is for broader comparison and routing. Medicine-specific detail still belongs on the narrower specialist sites.
Should I use the parent site first even if I think I already know the medicine name?
Often yes, especially if you are still comparing provider type, support or cost context rather than only current medicine-specific rows.
What if my question is only about tablets?
Then the parent tablet page remains the right main comparison, because tablet comparison stays native to this site.
Related articles
Important information
This website is an informational comparison hub. It does not prescribe, supply or sell prescription-only medicines. Suitability depends on a regulated clinical assessment.
Some links may be affiliate or commercial links. Commercial relationships must not change the way safety, eligibility, source checks or editorial context are presented.